EUVIMEDEUVIMED entdecken
Crossref

Phytochemical investigation and anti-inflammatory potential of Erica cinerea

Z Anwar, I Obaidi, M A Selo, E Dempsey, J Sendker, S Nagar, H Sheridan, J J Walsh

Planta Medica · 01.03.2026 · 92 (03) · 317-318

DOI: 10.1055/s-0045-1815181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von Z Anwar und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erica cinerea (bell heather), a member of the Ericaceae family, is native to central and western Europe and produces secondary metabolites such as anthocyanins, coumarins, flavonoids, and diarylnonanoids [ 1 ] [ 2 ]. While some studies highlight its potential as a urinary antiseptic and diuretic, its traditional use for inflammatory conditions remains underexplored [ 3 ]. As part of the ‘Unlocking Nature’s Pharmacy from Bogland Species’ (UNPBS) project, we have investigated the anti-inflammatory potential of E. cinerea using a bioactivity-guided approach. Initially, a crude methanolic extract of E. cinerea was prepared and tested for cell viability and its effects on IL-6, Rantes, TNF-α, and IL-1β using the THP-1 cell line stimulated with LPS, which yielded promising results. The extract was then fractionated using multiple chromatographic techniques, and the resulting fractions were evaluated for cell viability and anti-inflammatory activity. The most active fraction (EA 2.2) was subjected to LCMS, GCMS and HPTLC based profiling and finally four major compounds were isolated utilising column chromatography. The compounds were structurally characterised by NMR and mass spectrometry and identified as scopoletin, protocatechuic acid, ursolic acid and 3’’-hydroxy anhydroericanone. Of these, the compound 3’’-hydroxy anhydroericanone significantly suppressed LPS, PAM3CSK4, and IL-1β induced cytokine release, while the remaining three compounds showed minimal activity. Mechanistic studies indicated that 3’’-hydroxy anhydroericanone inhibited LPS induced NF-KB phosphorylation, suppressed NF-KB reporter activity, and reduced JNK and P38-MAPKs phosphorylation. This research emphasises the potential of E. cinerea extract, particularly 3’’-hydroxy anhydroericanone, a diarylnonanoid as the potential therapeutic candidate for the treatment of inflammatory conditions. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Anwar, Z., Obaidi, I., Selo, M. A., Dempsey, E., Sendker, J., Nagar, S., Sheridan, H., & Walsh, J. J. (2026). Phytochemical investigation and anti-inflammatory potential of Erica cinerea. Planta Medica, 92(03), 317-318. https://doi.org/10.1055/s-0045-1815181

Vancouver

Anwar Z, Obaidi I, Selo MA, Dempsey E, Sendker J, Nagar S, et al. Phytochemical investigation and anti-inflammatory potential of Erica cinerea. Planta Medica. 2026;92(03):317-318. doi:10.1055/s-0045-1815181

BibTeX
@article{Anwar2026,
  author = {Anwar, Z and Obaidi, I and Selo, M A and Dempsey, E and Sendker, J and Nagar, S and Sheridan, H and Walsh, J J},
  title = {Phytochemical investigation and anti-inflammatory potential of Erica cinerea},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {317--318},
  doi = {10.1055/s-0045-1815181}
}
Kostenlos starten →